Yes you are indeed talking in absolutes. You aren't taking into consideration that a deal or deals is /are being negotiated. You're assuming that a lengthy suspension is unjustifiable.
With biotechs the deals are often inordinately complex. I know this from another stock that I hold. Where negotiations are on foot for literally years. Suspensions have been necessary from time to time.
I don't think this is inordinate amount of time because obviously, if negotiations had ceased the reason for the suspension would end.
Be careful what you wish for. I don't wish for the suspension to end before deals are inked.
Doesn't stop me from being angry and having an opinion though.
Well nobody can force you to be logical I agree. But opinions are such that everyone's got one but we all need to revise our views from time to time or this is just a shouting venue and not a place for an exchange of ideas. IMO you're lacking in credibility if you agitate without including the relevant facts. Think about it a bit more is all I ask.
- Forums
- ASX - By Stock
- AVR
- Response received from Wayne on LinkedIn
Response received from Wayne on LinkedIn, page-79
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.02 |
Change
-0.890(8.98%) |
Mkt cap ! $196.8M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $200.2K | 21.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $9.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.57 | 98 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 329 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
1 | 200 | 8.500 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
9.290 | 173 | 3 |
9.300 | 1733 | 2 |
9.420 | 180 | 1 |
9.430 | 180 | 1 |
9.450 | 180 | 1 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online